Dr Gwen C Macdonald, MD | |
701 Dellwood St S, Cambridge, MN 55008-1920 | |
(763) 689-7700 | |
Not Available |
Full Name | Dr Gwen C Macdonald |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 701 Dellwood St S, Cambridge, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558491027 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 31611 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Gwen C Macdonald, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-5000 | Dr Gwen C Macdonald, MD 701 Dellwood St S, Cambridge, MN 55008-1920 Ph: (763) 689-7700 |
News Archive
As part of its ongoing advocacy to lower drug prices and increase access to lifesaving medications AIDS Healthcare Foundation, the largest global AIDS organization, today urged all AIDS drug manufacturers to reduce the cost of their medications by 20% for cash-strapped state.
The Transplant Institute at NYU Langone Health has launched a new lung transplant program, the third program of its kind in the greater New York City area, expanding regional access to this specialized level of care.
New research from Caltech shows that sour-sensing taste cells play an important role in detecting water on the tongue.
Ablative Solutions, Inc., a privately-held clinical stage company headquartered in Kalamazoo, MI, with offices in Menlo Park, CA, announced today that it has completed a Series B Preferred Stock financing, totaling approximately $9.5 million (including the conversion of the bridge financing completed in 2013), to fund its unique technology platform for renal denervation.
AbbVie, a global biopharmaceutical company, today announced data showing that patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection who received the recommended regimen of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets), with or without ribavirin (RBV), achieved high sustained virologic response rates at 48 weeks post-treatment (SVR48), regardless of the presence of baseline resistance-associated variants (RAVs).
› Verified 3 days ago
Lisa Marie Schweiger, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 | |
Christopher Lawrence Filetti, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 | |
Rachel M Naslund, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-8700 | |
Timothy J Probst, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 | |
Abbe Jennifer Penziner-bokde, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 612-262-1166 Fax: 612-262-4258 |